首页> 外文期刊>Colorectal cancer. >Resectable liver metastases from colorectal cancer: where we are now and where do we go from here?
【24h】

Resectable liver metastases from colorectal cancer: where we are now and where do we go from here?

机译:大肠癌可切除的肝转移:我们现在在哪里,我们从这里去哪里?

获取原文
获取原文并翻译 | 示例
       

摘要

Liver metastases from colorectal cancer represent a peculiar clinical scenario in everyday practice, since treatment should achieve long-term survival or even a cure in selected patients. Presentation may vary between single cases, ranging from easily resectable lesions to more advanced metastatic spreading for which surgery can only be considered after major tumor shrinkage. For resectable liver metastases, surgery remains the essential step in the curative approach to the disease, even though different ablative procedures may be considered as valuable alternatives in certain subsets. Postoperative or perioperative chemotherapy may further improve long-term outcome, even though treatment benefits and harms related to liver toxicity should be carefully balanced in each patient. A comprehensive multidisciplinary assessment of patient- and tumor-related features remains the key to complement the clinical aspects with the biological characterization in the framework of a personalized therapeutic approach.
机译:大肠癌的肝转移在日常实践中代表一种特殊的临床情况,因为治疗应在选定的患者中实现长期生存甚至治愈。单个病例的表现可能有所不同,范围从容易切除的病变到更严重的转移性扩散,只有在出现大的肿瘤缩小后才能考虑手术。对于可切除的肝转移,即使在某些亚组中不同的消融方法可能被视为有价值的替代方法,手术仍然是治愈该疾病的必不可少的步骤。术后或围手术期化疗可能会进一步改善长期预后,即使在每位患者中应仔细权衡与肝毒性相关的治疗益处和危害。对患者和肿瘤相关特征进行全面的多学科评估仍然是在个性化治疗方法框架内通过生物学表征补充临床方面的关键。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号